Rallybio Corp Stock Performance
| RLYB Stock | USD 10.55 0.04 0.38% |
Rallybio Corp holds a performance score of 14 on a scale of zero to a hundred. The company holds a Beta of -0.0817, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Rallybio Corp are expected to decrease at a much lower rate. During the bear market, Rallybio Corp is likely to outperform the market. Use Rallybio Corp expected short fall, and the relationship between the maximum drawdown and rate of daily change , to analyze future returns on Rallybio Corp.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Rallybio Corp are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Rallybio Corp sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (1.87) | Five Day Return 54.94 | Year To Date Return 85.6 | Ten Year Return (90.69) | All Time Return (90.69) |
Last Split Factor 1:8 | Last Split Date 2026-02-06 |
1 | How risky is Rallybio Corporation stock now - Quarterly Market Review Growth Focused Stock Reports - DonanmHaber | 12/19/2025 |
2 | What margin trends mean for Rallybio Corporation stock - July 2025 Catalysts Weekly Stock Performance Updates - moha.gov.vn | 12/30/2025 |
3 | Guidance Update What drives Rallybio Corporations stock price - July 2025 Fed Impact Weekly Watchlist for Hot Stocks - baoquankhu1.vn | 01/20/2026 |
4 | Market Fear Does Rallybio Corporation stock benefit from AI growth - Chart Signals Community Consensus Trade Alerts - baoquankhu1.vn | 01/30/2026 |
5 | Acquisition by Boudreau Helen M of 28500 shares of Rallybio Corp at 0.3 subject to Rule 16b-3 | 02/04/2026 |
6 | Short Interest in Rallybio Corporation Expands By 21.5 | 02/17/2026 |
7 | Acquisition by Hunt Ronald of 14305 shares of Rallybio Corp at 4.45 subject to Rule 16b-3 | 02/18/2026 |
8 | Disposition of 789 shares by Lieber Jonathan I of Rallybio Corp at 5.06 subject to Rule 16b-3 | 02/23/2026 |
| Begin Period Cash Flow | 24.5 M | |
| Total Cashflows From Investing Activities | 33.5 M |
Rallybio Corp Relative Risk vs. Return Landscape
If you would invest 529.00 in Rallybio Corp on December 5, 2025 and sell it today you would earn a total of 522.00 from holding Rallybio Corp or generate 98.68% return on investment over 90 days. Rallybio Corp is currently generating 1.3965% in daily expected returns and assumes 7.6182% risk (volatility on return distribution) over the 90 days horizon. In different words, 68% of stocks are less volatile than Rallybio, and 72% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Rallybio Corp Target Price Odds to finish over Current Price
The tendency of Rallybio Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 10.55 | 90 days | 10.55 | near 1 |
Based on a normal probability distribution, the odds of Rallybio Corp to move above the current price in 90 days from now is near 1 (This Rallybio Corp probability density function shows the probability of Rallybio Stock to fall within a particular range of prices over 90 days) .
Rallybio Corp Price Density |
| Price |
Predictive Modules for Rallybio Corp
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Rallybio Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Rallybio Corp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Rallybio Corp Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Rallybio Corp is not an exception. The market had few large corrections towards the Rallybio Corp's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Rallybio Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Rallybio Corp within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.31 | |
β | Beta against Dow Jones | -0.08 | |
σ | Overall volatility | 1.24 | |
Ir | Information ratio | 0.17 |
Rallybio Corp Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Rallybio Corp for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Rallybio Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Rallybio Corp is way too risky over 90 days horizon | |
| Rallybio Corp appears to be risky and price may revert if volatility continues | |
| Rallybio Corp has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 636 K. Net Loss for the year was (57.77 M) with loss before overhead, payroll, taxes, and interest of (38.36 M). | |
| Rallybio Corp currently holds about 147.37 M in cash with (49.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.59. | |
| Rallybio Corp has a poor financial position based on the latest SEC disclosures | |
| Roughly 64.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Disposition of 789 shares by Lieber Jonathan I of Rallybio Corp at 5.06 subject to Rule 16b-3 |
Rallybio Corp Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Rallybio Stock often depends not only on the future outlook of the current and potential Rallybio Corp's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Rallybio Corp's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.4 M | |
| Cash And Short Term Investments | 65.5 M |
Rallybio Corp Fundamentals Growth
Rallybio Stock prices reflect investors' perceptions of the future prospects and financial health of Rallybio Corp, and Rallybio Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Rallybio Stock performance.
| Return On Equity | -0.21 | ||||
| Return On Asset | -0.28 | ||||
| Operating Margin | (32.67) % | ||||
| Current Valuation | (1.19 M) | ||||
| Shares Outstanding | 5.28 M | ||||
| Price To Book | 0.92 X | ||||
| Price To Sales | 83.87 X | ||||
| Revenue | 636 K | ||||
| Gross Profit | (38.36 M) | ||||
| EBITDA | (60.37 M) | ||||
| Net Income | (57.77 M) | ||||
| Cash And Equivalents | 147.37 M | ||||
| Cash Per Share | 4.59 X | ||||
| Total Debt | 154 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 21.20 X | ||||
| Book Value Per Share | 12.03 X | ||||
| Cash Flow From Operations | (49.28 M) | ||||
| Earnings Per Share | (2.56) X | ||||
| Market Capitalization | 56.53 M | ||||
| Total Asset | 68.11 M | ||||
| Retained Earnings | (293.02 M) | ||||
| Working Capital | 61.6 M | ||||
About Rallybio Corp Performance
By analyzing Rallybio Corp's fundamental ratios, stakeholders can gain valuable insights into Rallybio Corp's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Rallybio Corp has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Rallybio Corp has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.98) | (1.02) | |
| Return On Capital Employed | (1.12) | (1.18) | |
| Return On Assets | (0.98) | (1.02) | |
| Return On Equity | (1.08) | (1.13) |
Things to note about Rallybio Corp performance evaluation
Checking the ongoing alerts about Rallybio Corp for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Rallybio Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Rallybio Corp is way too risky over 90 days horizon | |
| Rallybio Corp appears to be risky and price may revert if volatility continues | |
| Rallybio Corp has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 636 K. Net Loss for the year was (57.77 M) with loss before overhead, payroll, taxes, and interest of (38.36 M). | |
| Rallybio Corp currently holds about 147.37 M in cash with (49.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.59. | |
| Rallybio Corp has a poor financial position based on the latest SEC disclosures | |
| Roughly 64.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Disposition of 789 shares by Lieber Jonathan I of Rallybio Corp at 5.06 subject to Rule 16b-3 |
- Analyzing Rallybio Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Rallybio Corp's stock is overvalued or undervalued compared to its peers.
- Examining Rallybio Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Rallybio Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Rallybio Corp's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Rallybio Corp's stock. These opinions can provide insight into Rallybio Corp's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Rallybio Stock analysis
When running Rallybio Corp's price analysis, check to measure Rallybio Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rallybio Corp is operating at the current time. Most of Rallybio Corp's value examination focuses on studying past and present price action to predict the probability of Rallybio Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rallybio Corp's price. Additionally, you may evaluate how the addition of Rallybio Corp to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stocks Directory Find actively traded stocks across global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |